Joseph Francis Hokello
Bioprospecting for HIV-1 latency reversing agent (prostratin) from indigenous medicinal plants for latency reversal in HIV-1 subtypes A and D in Uganda (HIV-1_AD_LRA study)-PHASE-3
Joseph Francis Hokello

Strategic Objectives

To develop an efficacious herbal remedy for HIV latency reversal that contributes to Uganda’s Vision 2040 and NDP IV by promoting universal health, reducing HIV burden, and fostering drug innovation and patents.